Guy Aaron Young (Guy A Young, G Young, Guy Young)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 58

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Cardiac Surgery

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Rita Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX). Blood (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Rita Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX). Blood (2024)
Kimberley Youkhana, Glaivy Batsuli, Suchitra Acharya, Osman Khan, Duc Quang Tran, Andrea Dvorak, Michael Recht, Guy Aaron Young, Robert F Sidonio, Yasmina Abajas
Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Steven W Pipe, Amy L Dunn, Guy Aaron Young
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia a and B with inhibitors. Expert review of hematology (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Margaret V Ragni, Guy Aaron Young, Glaivy Batsuli, Emily Bisson, Shannon L Carpenter, Stacy E Croteau, Adam Cuker, Randall G Curtis, Michael Denne, Bruce Ewenstein, Amber Federizo, Neil Frick, Kerry Funkhouser, Lindsey A George, W Keith Hoots, Shawn M Jobe, Emily Krava, Christopher James Langmead, Roger J Lewis, José López, Lynn Malec, Ziva Mann, Moses E Miles, Emma Neely, Ellis J Neufeld, Glenn F Pierce, Steven W Pipe, Lisa R Pitler, Leslie Raffini, Kathaleen M Schnur, Jordan A Shavit
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding. Expert review of hematology 16 (sup1) (2023)
Guy Aaron Young, Michael U Callaghan, Vinod Balasa, Amit Soni, Sanjay Ahuja, Jonathan C Roberts, Mindy L Simpson, Hande Kızılocak, Andrew Frick, Ali G Mokdad, Shan Xing, Jorge Caicedo
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Glaivy Batsuli, Allison P Wheeler, Angela Christine Weyand, Robert F Sidonio, Guy Aaron Young
Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort. American journal of hematology (2023)
Steven W Pipe, Kayla Douglas, Nina Hwang, Guy Aaron Young, Priya Patel, Patrick F Fogarty
Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Rukhmi Bhat, Guy Aaron Young, Anjali Sharathkumar
How we treat venous thromboembolism in children in the DOAC era. Blood (2023)
Piet Meijer, Flora Peyvandi, Guy Aaron Young, Rajiv K Pruthi, Silmara Aparecida de Lima Montalvão, Steve Kitchen
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors. International journal of laboratory hematology (2023)
Guy Aaron Young
Can we do something about ICH in hemophilia? Blood 138 (26) (2022)
Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y Doral, Stacy E Croteau, Thierry Lambert, Christine L Kempton, Steven W Pipe, Richard H Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Aaron Young, Victor Jimenez Yuste
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies. Blood advances (2022)
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jimenez Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Aaron Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors. Blood advances 6 (11) (2022)
Steven W Pipe, Cedric Hermans, Meera Chitlur, Manuel D Carcao, Giancarlo Castaman, Joanna A Davis, Jonathan Ducore, Amy L Dunn, Miguel A Escobar, Janna Journeycake, Osman Khan, Johnny N Mahlangu, Shannon L Meeks, Ismail Haroon Mitha, Claude Négrier, Ulrike Nowak-Göttl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, Guy Aaron Young, W Allan Alexander, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Evelyne Sauty, Thomas A Wilkinson, Amy D Shapiro
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Christoph Male, Christoph Königs, Sohan Dey, Tadashi Matsushita, Anders Holm Millner, Marek Zak, Guy Aaron Young, Gili Kenet
The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A. Blood advances (2022)
Elizabeth T Stephens, Anh Thy H Nguyen, Julie Jaffray, Brian R Branchford, Ernest K Amankwah, Neil A Goldenberg, Edward Vincent S Faustino, Neil A Zakai, Amy Stillings, Emily Krava, Guy Aaron Young, John H Fargo
Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium. Research and practice in thrombosis and haemostasis 6 (7) (2022)
Hande Kizilocak, Guy Aaron Young
Emerging drugs for hemophilia A: insights into phase II and III clinical trials. Expert opinion on emerging drugs (2021)
Hande Kızılocak, Elizabeth Marquez-Casas, Jemily Malvar, Roxana Carmona, Guy Aaron Young
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Camila Henriques de Aquino, Victoria Borg Debono, Federico Germini, Drashti Pete, Christine L Kempton, Guy Aaron Young, Robert Sidonio, Stacy E Croteau, Amy L Dunn, Nigel S Key, Alfonso Iorio
Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Jane A Mason, Guy Aaron Young
Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Julie Jaffray, Lisa Baumann Kreuziger, Brian Branchford, Choo Phei Wee, E Vincent S Faustino, Neil A Zakai, Stacy E Croteau, Michael Silvey, John H Fargo, James D Cooper, Nihal Bakeer, Amy Stillings, Emily Krava, Guy Aaron Young, Neil A Goldenberg
Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium. Journal of thrombosis and haemostasis : JTH (2021)
Cassandra P Wang, Guy Aaron Young, Courtney D Thornburg
Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A. Expert opinion on drug safety 20 (4) (2021)
Andreas Tiede, Kingsley Hampton, Victor Jimenez Yuste, Guy Aaron Young, Soraya Benchikh El Fegoun, Pratima Chowdary
Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Manuel Carcao, Maria Elisa Mancuso, Guy Aaron Young, Victor Jimenez Yuste
Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors. Expert review of hematology 14 (2) (2021)
Roxana Carmona, Hande Kızılocak, Elizabeth Marquez-Casas, Siobhan Vasquez, Lingyun Ji, Richard H Ko, Guy Aaron Young, Julie Jaffray
Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia. Pediatric blood & cancer 69 (3) (2021)
Miguel A Escobar, Giancarlo Castaman, Santiago Bonanad Boix, Michael Callaghan, Philippe de Moerloose, Jonathan Ducore, Cédric Hermans, Janna Journeycake, Cindy Leissinger, James Luck, Johnny N Mahlangu, Wolfgang Miesbach, Ismail Haroon Mitha, Claude G Negrier, Doris Quon, Michael Recht, Jean François Schved, Amy D Shapiro, Robert Sidonio, Alok Srivastava, Oleksandra Stasyshyn, Kateryna V Vilchevska, Michael Wang, Guy Aaron Young, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Christopher Macie, Thomas A Wilkinson, Craig Kessler
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Beatrice Nolan, Johnny N Mahlangu, Ingrid Pabinger, Guy Aaron Young, Barbara A Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, K John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Hande Kızılocak, Elizabeth Marquez-Casas, Choo Phei Wee, Jemily Malvar, Roxana Carmona, Guy Aaron Young
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Xiaofan Shen, Rachel Wile, Guy Aaron Young
FondaKIDS III: A long-term retrospective cohort study of fondaparinux for treatment of venous thromboembolism in children. Pediatric blood & cancer 67 (8) (2020)
Anthony K C Chan, Jayanthi Alamelu, Chris Barnes, Ampaiwan Chuansumrit, May-Lill Garly, Rikke Medom Meldgaard, Guy Aaron Young
Nonacog beta pegol (N9-GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients. Research and practice in thrombosis and haemostasis 4 (7) (2020)
Guy Aaron Young, Anthonie W A Lensing, Paul Monagle, Christoph Male, Kirstin Thelen, Stefan Willmann, Joseph S Palumbo, Riten Kumar, Ildar Nurmeev, Kerry Hege, Fanny Bajolle, Philip Connor, Hélène L Hooimeijer, Marcela Torres, Anthony K C Chan, Gili Kenet, Susanne Holzhauer, Amparo Santamaría, Pascal Amedro, Jan Beyer-Westendorf, Ida Martinelli, M Patricia Massicotte, William T Smith, Scott D Berkowitz, Stephan Schmidt, Victoria Price, Martin H Prins, Dagmar Kubitza, null null
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation. Journal of thrombosis and haemostasis : JTH 18 (7) (2020)
Maria Elisa Mancuso, Johnny N Mahlangu, Robert Sidonio, Peter Trask, Marianne Uguen, Tiffany Chang, Midori Shima, Guy Aaron Young, Johannes Oldenburg, Sylvia von Mackensen
Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Cornelia Heleen van Ommen, Manuela Albisetti, Anthony K C Chan, Jeremie Estepp, Julie Jaffray, Gili Kenet, Guy Aaron Young, Jay Dave, Michael A Grosso, Anil Duggal
The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease. Research and practice in thrombosis and haemostasis 4 (5) (2020)
Guy Aaron Young
Implications of the first FDA-approved anticoagulant in pediatrics: One ship has sailed but the next ones are at the dock. Pediatric blood & cancer 67 (12) (2020)
Colleen Harkins Druzgal, Hande Kizilocak, Joshua Brown, Margaret Sennett, Guy Aaron Young
Neutralizing antidrug antibody to emicizumab in a patient with severe hemophilia A with inhibitors: New case with detailed laboratory evaluation. Journal of thrombosis and haemostasis : JTH 18 (9) (2020)
Guy Aaron Young
Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance. Blood advances 2 (20) (2019)
Guy Aaron Young, David J Perry, null null
Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice. Journal of thrombosis and haemostasis : JTH 17 (4) (2019)
Louis M Aledort, Shannon L Carpenter, Adam Cuker, Roshni Daniel Kulkarni, Michael Recht, Guy Aaron Young, Cindy Leissinger
Why plasma-derived factor VIII? Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Guy Aaron Young
How I treat children with haemophilia and inhibitors. British journal of haematology 186 (3) (2019)
Manuel D Carcao, Carmen Escuriola-Ettingshausen, Elena Santagostino, Johannes Oldenburg, Ri Liesner, Beatrice Nolan, Angelika Bátorová, Saturnino Haya, Guy Aaron Young, null null
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Arash Mahajerin, Julie Jaffray, Brian Branchford, Amy Stillings, Emily Krava, Guy Aaron Young, Neil A Goldenberg, E Vincent S Faustino
Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism. Journal of thrombosis and haemostasis : JTH 18 (3) (2019)
Cedric Hermans, Johnny N Mahlangu, J Booth, Helmut Schütz, E Santagostino, Guy Aaron Young, H-Y Lee, K N Steinitz-Trost, V Blanchette, E Berntorp
Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII. Haemophilia : the official journal of the World Federation of Hemophilia 24 (3) (2018)
Cassandra P Wang, Guy Aaron Young
Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia 24 (3) (2018)
Johnny N Mahlangu, Guy Aaron Young, Cedric Hermans, V Blanchette, E Berntorp, E Santagostino
Defining extended half-life rFVIII-A critical review of the evidence. Haemophilia : the official journal of the World Federation of Hemophilia 24 (3) (2018)
Johannes Oldenburg, Manuel D Carcao, Steven R Lentz, Johnny N Mahlangu, Maria Elisa Mancuso, Tadashi Matsushita, Claude Négrier, Wan Hui Ong Clausen, Silke Ehrenforth, Guy Aaron Young
Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Johannes Oldenburg, Johnny N Mahlangu, Willem Bujan, Peter Trask, Michael U Callaghan, Guy Aaron Young, Elina Asikanius, Flora Peyvandi, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler, Jin Xu, Jerzy Windyga, Midori Shima, Sylvia von Mackensen
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)
Guy Aaron Young, Roxana Carmona, Viridiana Cano Garcia
Thromboelastography and thrombin generation assay in inherited afibrinogenemia. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Guy Aaron Young, M Ezban, W H O Clausen, C Negrier, J Oldenburg, M Shima
Chromogenic analysis of FIX activity in haemophilia B patients treated with nonacog beta pegol. Haemophilia : the official journal of the World Federation of Hemophilia 23 (6) (2017)
Guy Aaron Young
How I treat pediatric venous thromboembolism. Blood 130 (12) (2017)
Ruchika Sharma, A Dunn, D Aschman, D Cheng, A Wheeler, A Soni, C McGuinn, C Knoll, D T Stein, Guy Aaron Young, J French, J Sanders, J A Davis, M Tarantino, Ming Y Lim, R Gruppo, R Sidonio, S Ahuja, S Carpenter, S Pipe, A Shapiro
Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset. Haemophilia : the official journal of the World Federation of Hemophilia 23 (4) (2017)